1-Month and 2-Month subcutaneous risperidone for schizophrenia Commercialized in the U.S. since May 2023 2024 sales: $117 million, Q1 2025 sales: $39 million, 2.6x increase compared to Q1 2024 ...

Notes and all the accrued interest, until this date.

held on 23 May 2025 at 12:00 CET. The Annual General Meeting will be held as a digital meeting only, with no physical attendance for shareholders. Further information ...

Watch CEO Gerald Pötzsch and CFO Richard Hallström present ContextVision's highlights from Q1 2025 along with the financials for the quarter.

Wednesday, May 14th at 06:00 CET. An audio webcast will take place on the same day at 10:00 CET. The audio webcast targets investors, analysts and media. Attendees will be able to post questions in a ...

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, is pleased to announce a strategic partnership with Stasher, the world’s first ...

· Partnership signed with the University of Washington as we progress our aim · Revenue of 26.3 MSEK (34.7) , down 24,2%. · EBITDA amounted to -1.6 MSEK (12.8) with an EBITDA margin of -6.3% (36.9). · ...

Record sales of NOK 44.5 million in 1Q25, up 16% vs 1Q24 (13% organic growth). Sales of Cystatin C increased with 18% in 1Q25 compared to 1Q24. Strong increase in sales to China indicates a return ...

approximately US$19,000 per day, gross. - The Company declared total dividends and cash distributions of US$0.10 per share for the months of January, February and March 2025. - Completed drydocking ...

that occurred on 4 March. Since then, the production ramp-up has continued and on 30 April production reached 23.4 mboepd net to the Company with 88% of Tyra wells commissioned and c. 60% of Tyra ...

Estelle Brachlianoff, CEO of the Group, stated: “In the first quarter of 2025, Veolia once again demonstrated the relevance of its business model, which combines resilience and growth, by achieving ...

Sales growth (organic and acquisitions) : +11.2% Adjusted operating margin : 20.7% (after acquisitions) Net profit attributable to the Group: 12.9% of sales ...